With the new BECO CARBON™ ACF 03 grade, Eaton is responding to the growing demand for user-friendly activated carbon sheets tested for endotoxins for pharmaceutical and biopharmaceutical applications, fine chemicals and other industries.
Clean Rooms | 21/04/2023 | By Manvi
BES completes $4.8m pharma facility refurb for Recipharm
The 4000 sq mt facility, located in King’s Lynn, England, has seen an extensive redesign and refurbishment
Clean Rooms | 23/03/2023 | By Sudeep Soparkar
Clean Cells opens new facility in Montaigu France
The company plans to recruit 20 new staff members in 2023
Clean Rooms | 06/03/2023 | By Sudeep Soparkar
Puritas Asgard completes API facility cleanroom expansion
The facility will manufacture APIs critical for critical medications and life-saving drugs
Clean Rooms | 28/02/2023 | By Sudeep Soparkar
Charles River Laboratories International expands CDMO facility in Memphis, Tenn
The expanded space is suitable for clinical and commercial cell therapy manufacturing, with an additional nine state-of-the-art processing suites, adding to an existing 16 cleanrooms
Clean Rooms | 14/11/2022 | By Sudeep Soparkar
Medhini Group signs MOUs with multiple India-based cleanroom experts
Medhini is using these two companies to uplift programmes for pharmaceutical manufacturing in Malaysia
Clean Rooms | 04/10/2022 | By Sudeep Soparkar | 125
Cleanroom tech market size to hit $11.46 bn by 2030: Growth Plus Reports
North America dominates the global market with the largest revenue share
Clean Rooms | 18/08/2022 | By Sudeep Soparkar | 115
2nd Annual Next Generation Pharmaceutical Cleanroom Conference will be held in London
The event from October 5 and 6 will focus on cleanroom technology in the pharmaceutical industry
Clean Rooms | 22/07/2022 | By Sudeep Soparkar | 116
The deadline for voluntary registration of Class A and Class B medical devices with the regulator ended on September 30, 2021 and registration became compulsory from October 1, 2021. Manufacturers are required to complete mandatory registration with the CDSCO by September 30, 2022. It has come to the notice that a significant number
Clean Rooms | 16/02/2022 | By Darshana | 145
Novartis inks option, collaboration & licensing pact with BeiGene for TIGIT inhibitor ociperlimab
Novartis announced the signing of an option, collaboration and license agreement with BeiGene, Ltd. for ociperlimab (BGB-A1217), expanding the company?s research and development activities in immuno-oncology. Ociperlimab is a late-stage TIGIT inhibitor, a novel class of anti-cancer therapies that blocks the TIGIT protein receptor
Clean Rooms | 22/12/2021 | By Darshana | 173
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy